No abstract available.
Creatinine*

No abstract available.
Creatinine* ; Humans

No abstract available.
Creatinine* ; Plasma*

Creatinine (Cr) is a representative biomarker reflecting renal function. In this study, we compared serum Cr levels using Roche Modular D (Roche Diagnostics, Germany), Roche Cobas 8000 c702 (Roche Diagnostics), and AU5800 (Beckman Coulter, USA). In addition, we assessed the differences in Cr measurements using the Jaffe and enzymatic methods.METHODS: Precision, linearity, and methods were evaluated in accordance with CLSI guidelines. Serum Cr was measured by Modular D following the Jaffe method, and serum Cr was measured by Cobas 8000 c702 and AU5800, following the Jaffe and enzyme methods.RESULTS: All of the total coefficients of variations (CVs) were below 5%. Linearity was observed in the performance ranges evaluated (r>0.99, slope: 0.965 and 0.955). When Modular D and Cobas 8000c 702 were compared, the slope and y-intercept were 0.9928 (95% confidence interval [CI]: 0.9802 to 1.000) and -0.0156 (95% CI: −0.0200 to −0.0054), respectively. The slope and y-intercept were 0.9811 (95% CI: 0.9570 to 0.9951) and -0.0484 (95% CI: −0.0638 to −0.0297) when Modular D and Au5800 were compared. Serum Cr measured by Cobas 8000 c702 and AU5800 using the Jaffe method were 3.2% and 6.9% lower than the values measured by Modular D, respectively. Both Modular D and Cobas 8000 c702 showed acceptable accuracies.CONCLUSIONS: Serum Cr measurements using Cobas 8000 c702 and AU5800 were comparable to those measured by Modular D, and showed satisfactory precision and linearity; thus, these techniques could be useful for clinical laboratories.]]>
Creatinine ; Methods

The research studied urinary beta2-microglobulin excretion to detect tubular dysfunction in 31 patients with primary nephrotic syndrome. The result showed the increased excretion of beta2-microglobulin was observed in 11/31 cases. There were no sighgicant differences of the urinary creatinine excreation and between group of patients with increased urinary beta2-microglobulin excretion and the group without it. This indicated having combine tubular dysfunction in patients with primary nephrotic syndrome. The finding might suggest the use of urinary beta2-microglobulin for detecting the associated tubular disfuntion in such patients
Diagnosis ; Creatinine ; Beta-Globulins

Creatinin level in control group was 93.55 ± 10.96 micromol/l. This level in exposed group was 114.03 ± 9.72 micromol/l. Renal creatinin clearance control group was 81.0 ± 4.0 micromol/l and in exposed group was 70.71 ± 9.0 micromol/l. There was not a relationship between hair lead level and renal creatinin and renal clearance but the length of service clearly influenced creatinin level and renal clearance
Creatinine ; Kidney ; Hair

No abstract available.
Creatinine* ; Humans ; Infant, Newborn*

Extracorporeal shock wave lithotripsy(ESWL) has become a major treatment modality for symptomatic renal stone disease. Although ESWL was proved to be effective in disintegrating stones it is known that some radiological evidence of transient renal malfunction could be possible after ESWL. However. it has been difficult to assess the renal damage quantitatively. We evaluated several basic physiologic parameters namely, total protein excretion, creatinine clearance and beta-2-microglobulin excretion in aliquots of 24 hour urine samples. ESWL was performed using Siemens Lithostar device. In a total of. 33 patients urine samples were obtained before, 1 day and 7 days after ESWL without prior manipulation. Our data showed that transient increased protein excretion and decreased creatinine clearance occur immediately after treatment, and return to pre-procedure levels within 7 days without a change in beta-2-microelobulin excretion after ESWL. Conclusively, renal damage induced by ESWL is thought to be transient and of limited magnitude of brief duration.
Creatinine ; Humans ; Lithotripsy* ; Shock*

No abstract available.
Creatinine* ; Kidney Failure, Chronic*

OBJEVTIVE: To evaluate the peritoneal clearance of the middle molecule compared with that of the small molecule in incremental peritoneal dialysis(PD). METHODS: Peritoneal clearances of the creatinine and beta2-microgloblulin were compared in 57 continuous ambulatory PD patients with full dose 4 times exchange and in 54 incremental PD patients with 2 or 3 times exchange over 24 hours. The clearances were also compared when there were changes in the peritoneal dialysis regimen such as in the number of exchanges and dwelling time. RESULTS: Peritoneal creatinine clearance increased almost linearly along with the increase in the number of exchanges. In contrast, peritoneal clearance of beta2-microglobulin was 9.1+/-3.6 L/week, 8.8+/-4.4 L/ week, and 7.9+/-2.5 L/week respectively with 2, 3 and 4 exchanges per day, not different from each other. Peritoneal clearance of beta2-microglobulin did not change when there was an increase in the number of exchange from 2 to 3 times and 3 to 4 times over a period of 24 hours, whereas the peritoneal clearance of creatinine increased. Peritoneal clearance of beta2-microglobulin almost doubled from 5.4+/-2.7 L/ week with 2 times exchange over 12 hours per day, to 9.5+/-4.4 L/week with 2 times exchange over 24 hours, whereas the creatinine clearance did not change. CONCLUSION: In contrast to peritoneal clearance of small molecule which depends on the number of dialysate exchange, peritoneal clearance of middle molecule depends mainly on the total dwelling hours rather than the number of exchange per day in incremental PD. This can be another advantage of incremental PD since peritoneal clearance of middle molecules in incremental PD over 24 hours is comparable to that in full dose PD.
Creatinine ; Humans ; Peritoneal Dialysis*